| COVID-19 |
1 |
1 |
| Pandemic |
0 |
0.85 |
| Vaccines |
0 |
0.65 |
| Biologic Therapy |
0 |
0.59 |
| Acute Respiratory Distress Syndrome |
0 |
0.4 |
| Revenue and Practice Management |
0 |
0.26 |
| Severe Acute Respiratory Syndrome |
0 |
0.25 |
| Otolaryngology |
0 |
0.18 |
| Antigens |
0 |
0.17 |
| Face |
0 |
0.17 |
| Hospital |
0 |
0.17 |
| Maryland |
0 |
0.17 |
| Influenza |
0 |
0.11 |
| Tropical Diseases |
0 |
0.11 |
| Tuberculosis |
0 |
0.11 |
| Wound Management |
0 |
0.11 |
| Fatigue |
0 |
0.09 |
| Fellowship |
0 |
0.09 |
| Immunization |
0 |
0.09 |
| Injury |
0 |
0.09 |
| Internet |
0 |
0.09 |
| Malaria |
0 |
0.09 |
| Nose |
0 |
0.09 |
| Polio |
0 |
0.09 |
| Prisons |
0 |
0.09 |
| Private Practice |
0 |
0.09 |
| Residency |
0 |
0.09 |
| Smallpox |
0 |
0.09 |
| Tolerance |
0 |
0.09 |
| Travel Medicine |
0 |
0.09 |